The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of LBL-007 (anti-LAG-3) plus tislelizumab (anti-PD-1) and chemotherapy as first-line treatment in patients with unresectable locally advanced/metastatic esophageal squamous cell carcinoma.
 
Yi Ba
No Relationships to Disclose
 
Jing Zhang
No Relationships to Disclose
 
Haiyan Liu
No Relationships to Disclose
 
Tongsen Zheng
No Relationships to Disclose
 
Xueqiang Zhu
No Relationships to Disclose
 
Yubei Sun
No Relationships to Disclose
 
Wei Ren
No Relationships to Disclose
 
Bhumsuk Keam
Honoraria - AstraZeneca; Bayer; LG Chem; MSD Oncology; Yuhan
Consulting or Advisory Role - Handok; ImmuneOncia; TiumBio; Trial Informatics; Yuhan
Research Funding - AstraZeneca; MSD Oncology; Ono Pharmaceutical
 
I-Chen Wu
No Relationships to Disclose
 
Krittiya Korphaisarn
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; MSD Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca; MSD Oncology; Roche; Takeda
Research Funding - AstraZeneca (Inst); BeiGene (Inst); MSD Oncology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Eisai; MSD Oncology; Roche; Zuellig Pharma
 
Qiao Li
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
 
Xiao Lin
Employment - BeOne Medicines
 
Jinhui Zhang
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
 
Huiyan Li
Employment - BeOne Medicines
Stock and Other Ownership Interests - BeOne Medicines
Travel, Accommodations, Expenses - BeOne Medicines
 
Sook Ryun Park
Honoraria - MSD
Consulting or Advisory Role - BeiGene; Pfizer
Research Funding - ImmuneOncia; Incyte; Ono Pharmaceutical